Showing results (781-790 of 944) with videos related to

Sort By:
Pageof 95
Annals of Surgery|September 1, 1988
Surgical experience with thirteen conjoined twinsJ A O'Neill, G W Holcomb, L Schnaufer, et al.
Investigative Ophthalmology & Visual Science|December 31, 2005
Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroidIvana K Kim, Deeba Husain, Norman Michaud, et al.
Diabetes, Obesity & Metabolism|January 5, 2019
Double-blind, randomized clinical trial assessing the efficacy and safety of early initiation of sitagliptin during metformin uptitration in the treatment of patients with type 2 diabetes: The CompoSIT-M studyJuan P Frias, Zachary Zimmer, Raymond L H Lam, et al.
Bone Marrow Transplantation|February 1, 1996
PCR amplification of short tandem repeat sequences allows serial studies of chimaerism/engraftment following BMT in rodentsP A O'Neill, M Lawler, R Pullens, et al.
Current Medical Research and Opinion|December 31, 2016
A randomized clinical trial of the safety and efficacy of sitagliptin in patients with type 2 diabetes mellitus inadequately controlled by acarbose aloneWeiqing Wang, Guang Ning, Jianhua Ma, et al.
Molecular Therapy. Methods & Clinical Development|January 17, 2022
Molecular analysis of AAV5-hFVIII-SQ vector-genome-processing kinetics in transduced mouse and nonhuman primate liversChoong-Ryoul Sihn, Britta Handyside, Su Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2014
Protective role for caspase-11 during acute experimental murine colitisKatarzyna Oficjalska, Mathilde Raverdeau, Gabriella Aviello, et al.
Current Medical Research and Opinion|April 9, 2015
Long-term efficacy of sitagliptin as either monotherapy or add-on therapy to metformin: improvement in glycemic control over 2 years in patients with type 2 diabetesH L Katzeff, D Williams-Herman, L Xu, et al.
The Journal of Experimental Medicine|February 1, 1996
T cell responses in calcineurin A alpha-deficient miceB W Zhang, G Zimmer, J Chen, et al.
International Journal of Cancer|November 13, 2008
Seliciclib (CYC202, R-roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft modelMaria Virginia C L Appleyard, Mary A O'Neill, Karen E Murray, et al.
Pageof 95